Marker Therapeutics (MRKR) Financials

$1.28

$0.10 (8.47%)

As on 08-Sep-2026 16:02EDT

Market cap

$20 Mln

Revenue (TTM)

$2 Mln

P/E Ratio

--

P/B Ratio

1.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	2.34	3.55	6.59	3.31	3.51	1.24
Cost of Revenue	5.19	--	13.47	10.42	11.97	3.16
Gross Profit	-3.96	--	-6.88	-7.11	-8.45	-1.92
Operating Expenses	6.76	12.89	4.24	7.48	11.34	37.56
Operating Profit (EBIT)	-10.71	-12.89	-11.12	-14.58	-19.79	-39.48
Other Income	--	--	--	--	--	--
Profit before Tax	-8.72	-12.18	-10.68	-14.04	-19.78	-41.88
Provision for Tax	-0.02	-0.02	0.05	0.00	-0.02	-0.01
Profit after Tax (Net Income)	-8.71	-12.16	-10.73	-8.24	-29.93	-41.88
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-41.88

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	12.17	16.80	18.56	14.05	19.60	43.99
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	--	7.04	11.25
Current Liabilities	2.42	2.27	3.46	3.07	7.78	12.90
Total Liabilities	17.01	19.07	22.02	17.13	34.42	68.14

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	--	--	--	--	17.80	22.15
Current Assets	14.59	19.07	22.02	17.13	16.62	45.98
Total Assets	17.01	19.07	22.02	17.13	34.42	68.14
Total Debt*	--	--	--	--	7.62	11.87
Net Current Assets	12.17	16.80	18.56	14.05	8.84	33.08

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-12.01	-10.91	-16.44	-26.97	-27.28
Cash Flow from Investing Activities	--	--	--	18.66	-4.95	-3.13
Cash from Financing Activities	--	9.86	14.99	1.11	0.20	52.56
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.49	-0.79	-1.18	-0.93	-3.56	-5.04
Cash EPS ($)	--	-0.79	-1.18	-0.93	-3.13	-4.66
Adjusted Book Value ($)	--	1.10	2.04	1.58	2.33	5.29
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.78	-1.20	-1.85	-3.21	-3.28
Free Cash Flow per Share ($)	--	-0.78	-1.20	-1.85	-3.21	-3.66

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-68.81	-65.81	-39.92	-72.06	-87.75
ROE (%)	-60.13	-68.81	-65.81	-48.95	-94.14	-117.42
ROA (%)	-48.31	-59.20	-54.82	-31.96	-58.37	-73.63
EBIT Margin (%)	-85.55	--	-162.06	-424.09	-562.85	-3,372.68
Net Margin (%)	-372.69	-342.96	-162.82	-248.76	-851.87	-3,372.68
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-56.64	-0.46	0.99	-0.06	1.83	1.66
EBIT Growth (%)	87.82	--	23.93	28.99	52.78	-45.89
Net Profit Growth (%)	40.39	-13.35	-30.28	72.48	28.53	-45.89
EPS Growth (%)	64.22	0.33	-0.27	0.74	0.29	0.15
Book Value Growth (%)	-16.20	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.88	-2.64	-5.94	-0.07	-0.19
Price / Book Value	1.78	1.36	1.53	3.48	0.11	0.18
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.22	-0.54	1,796,813.49	-3.01	0.11	0.58
Close Price ($)	1.47	1.49	3.11	5.50	2.66	9.50
High Price ($)	4.07	4.07	5.99	9.68	10.30	37.70
Low Price ($)	0.81	0.81	2.44	0.67	2.20	9.00
Market Cap ($ Cr)	19.67	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	--	--	0.39	0.27
Short term debt to equity ratio	--	--	--	--	0.03	0.01
Current Ratio	6.03	8.39	6.36	5.57	2.14	3.56
Quick Ratio	6.03	--	--	5.89	--	--
Interest Coverage	--	--	--	--	-1,310.62	-7,347.17

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	69.32	38.60	35.60	31.04	68.36	0.02
Asset Turnover	0.13	0.17	0.34	0.13	0.07	0.02
Receivable days	--	191.33	93.50	189.17	124.86	147.19
Inventory Days	--	--	-26.80	-34.65	--	-115.49
Payable days	--	--	27.49	36.15	95.29	466.52
Cash Conversion Cycle	--	--	39.22	118.37	--	-434.81

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.